Literature DB >> 23925666

Association analysis between MDR1 genetic variant and breast cancer risk factors in Chinese Han population.

Yi Hu1, Jingliang Wang, Haitao Tao, Huan Wang, Xin Zhang, Yao Cheng, Ruixin Li.   

Abstract

The multidrug resistance 1 gene (MDR1) is an important candidate gene for influencing breast cancer susceptibility. This study aimed to evaluate the association between MDR1 genetic variants and breast cancer susceptibility. A total of 340 breast cancer patients and 348 cancer-free controls were enrolled in this study. The patients' general characteristics and related risk factors of breast cancer were collected by questionnaires. The c.4125A>C genetic variant was genotyped through created restriction site polymerase chain reaction method. Our data suggest that there are no significant differences in the allelic and genotypic frequencies between breast cancer patients and cancer-free controls. Moreover, the distribution of breast cancer patients' risk factors is not different among AA, AC, and CC genotypes. These preliminary results suggest that the c.4125A>C genetic variant is not significantly associated with breast cancer susceptibility.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925666     DOI: 10.1007/s12032-013-0683-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  30 in total

1.  MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.

Authors:  Xiaojing Sheng; Limei Zhang; Na Tong; Dewei Luo; Meilin Wang; Min Xu; Zhengdong Zhang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 2.  Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.

Authors:  Furu Wang; Qiaoqiao Fang; Zhen Ge; Ningle Yu; Sanxiao Xu; Xiangyong Fan
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

3.  Genetic polymorphism of CYP17 and breast cancer risk in Korean women.

Authors:  Myung-Hee Shin; Kyoung-Mu Lee; Jung-Hyun Yang; Seok Jin Nam; Jong-Won Kim; Keun-Young Yoo; Sue Kyung Park; Dong-Young Noh; Sei-Hyun Ahn; Bongcheol Kim; Daehee Kang
Journal:  Exp Mol Med       Date:  2005-02-28       Impact factor: 8.718

4.  Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle.

Authors:  Zhengrong Yuan; Junya Li; Jiao Li; Xue Gao; Huijiang Gao; Shangzhong Xu
Journal:  Mol Biol Rep       Date:  2012-11-10       Impact factor: 2.316

Review 5.  Adjuvant therapy of primary breast cancer: a review of key findings from the 7th international conference, St. Gallen, February 2001.

Authors:  M S Aapro
Journal:  Oncologist       Date:  2001

6.  Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.

Authors:  Annemarie Larkin; Lorraine O'Driscoll; Susan Kennedy; Rachel Purcell; Elizabeth Moran; John Crown; Michael Parkinson; Martin Clynes
Journal:  Int J Cancer       Date:  2004-11-01       Impact factor: 7.396

Review 7.  Breast cancer in Iran: an epidemiological review.

Authors:  Seyed Mohsen Mousavi; Ali Montazeri; Mohammad Ali Mohagheghi; Alireza Mousavi Jarrahi; Iraj Harirchi; Masomeh Najafi; Mandana Ebrahimi
Journal:  Breast J       Date:  2007 Jul-Aug       Impact factor: 2.431

8.  SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene.

Authors:  Zhengrong Yuan; Jiao Li; Junya Li; Xue Gao; Shangzhong Xu
Journal:  Mol Biol Rep       Date:  2012-11-01       Impact factor: 2.316

9.  Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China.

Authors:  Lei Fan; Ying Zheng; Ke-Da Yu; Guang-Yu Liu; Jiong Wu; Jin-Song Lu; Kun-Wei Shen; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Breast Cancer Res Treat       Date:  2009-01-20       Impact factor: 4.872

10.  Investigation on MDR1 gene polymorphisms and its relationship with breast cancer risk factors in Chinese women.

Authors:  Yi Fang; Qingyu Zhao; Gang Ma; Yujing Han; Ning Lou
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

View more
  1 in total

1.  XRCC1 genetic polymorphism acts a potential biomarker for lung cancer.

Authors:  Dao-Qi Zhu; Qiong Zou; Chun-Hong Hu; Jia-Li Su; Guang-Hua Zhou; Ping Liu
Journal:  Tumour Biol       Date:  2015-01-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.